Pacific Biosciences Of California | PACB - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Agilent USD 1.81B 49M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Danaher USD 4.35B 1.35B 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Illumina USD 1.42B 368M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 462M 125.83M 2026-03